Novartis AG (NVSEF)
127.40
+0.78
(+0.62%)
USD |
OTCM |
Dec 11, 16:00
Novartis Shareholders Equity (Quarterly): 44.33B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Roche Holding AG | -- |
| BeOne Medicines Ltd. | 4.129B |
| AC Immune SA | 78.48M |
| CRISPR Therapeutics AG | 1.916B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.29B |
| Total Liabilities (Quarterly) | 62.54B |
| Debt to Equity Ratio | 0.7224 |
| Current Ratio | 0.8812 |
| Net Debt Paydown Yield | -0.26% |